University of Texas's MD Anderson Cancer: Nano-Sized Vesicles With ACE2 Receptor Could Prevent, Treat Infection From Current and Future Strains of SARS-CoV-2
January 21, 2022
January 21, 2022
HOUSTON, Texas, Jan. 21 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Jan. 20, 2022:
* * *
Study identifies naturally occurring vesicles in patients as part of anti-viral response
* * *
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 pat . . .
* * *
Study identifies naturally occurring vesicles in patients as part of anti-viral response
* * *
Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 pat . . .